Regeneron Pharmaceuticals, Inc. faces Eylea revenue decline but shows growth potential with Dupixent & Libtayo. Click for ...

Japan’s Shionogi (TYO: 4507) yesterday delivered a late-breaking scientific oral presentation at the Conference of ...

The electric SUV is going through the last stages of development in South Africa, together with the closely-related sedan.

The Canadian singer-songwriter talked style strategies, accessory faves and travel tips from the front row at Chanel ...

"My community recently witnessed a tragedy that made me think about my family and our safety. I began to consider an everyday, household item paired with safety features that could save future lives ...

International medical imaging IT and cybersecurity company Sectra's (STO: SECT B) enterprise imaging module for radiology is ranked number one ...

Q4 2024 Earnings Call Transcript March 13, 2025 Operator: Good morning, everyone. Thank you for joining Acacia Research’s ...

Q4 2024 revenue increased 24.6% over Q3 2024; Full-year 2024 revenue grew 97.8% year-over-yearStrong growth in key commercial metrics, including ...

Updated Phase 1 data for ELVN-001 expected mid-2025 as positive enrollment momentum continues Expected monotherapy and combination data from the ELVN-002 Phase 1 trials ...

Evoke Pharma, Inc. ( NASDAQ: EVOK) Q4 2024 Earnings Conference Call March 13, 2025 4:30 PM ET Daniel Kontoh-Boateng – DKB Partners Matt D’Onofrio – Chief Executive Officer Chris Quesenberry – Chief ...

Detailed price information for Natural Alternativ (NAII-Q) from The Globe and Mail including charting and trades.